Bristol Free Cash Flow Per Share from 2010 to 2025

BMY Stock  USD 56.29  0.09  0.16%   
Bristol Myers Free Cash Flow Per Share yearly trend continues to be fairly stable with very little volatility. Free Cash Flow Per Share is likely to outpace its year average in 2025. Free Cash Flow Per Share is the amount of cash Bristol Myers Squibb generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. View All Fundamentals
 
Free Cash Flow Per Share  
First Reported
2010-12-31
Previous Quarter
5.5
Current Value
5.78
Quarterly Volatility
2.17927334
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as Depreciation And Amortization of 11.8 B, Interest Expense of 1.4 B or Selling General Administrative of 3.6 B, as well as many indicators such as Price To Sales Ratio of 2.98, Dividend Yield of 0.0374 or PTB Ratio of 6.92. Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
  
Check out the analysis of Bristol Myers Correlation against competitors.

Latest Bristol Myers' Free Cash Flow Per Share Growth Pattern

Below is the plot of the Free Cash Flow Per Share of Bristol Myers Squibb over the last few years. It is the amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share. Bristol Myers' Free Cash Flow Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bristol Myers' overall financial position and show how it may be relating to other accounts over time.
Free Cash Flow Per Share10 Years Trend
Slightly volatile
   Free Cash Flow Per Share   
       Timeline  

Bristol Free Cash Flow Per Share Regression Statistics

Arithmetic Mean3.59
Geometric Mean2.70
Coefficient Of Variation60.77
Mean Deviation1.89
Median3.83
Standard Deviation2.18
Sample Variance4.75
Range6.553
R-Value0.81
Mean Square Error1.75
R-Squared0.66
Significance0.0001
Slope0.37
Total Sum of Squares71.24

Bristol Free Cash Flow Per Share History

2025 5.78
2024 5.5
2023 6.11
2022 5.61
2021 6.86
2020 5.89
2019 4.24

About Bristol Myers Financial Statements

Bristol Myers investors use historical fundamental indicators, such as Bristol Myers' Free Cash Flow Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bristol Myers. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Free Cash Flow Per Share 5.50  5.78 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bristol Stock Analysis

When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.